Literature DB >> 11024144

Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells.

W Chehadeh1, J Kerr-Conte, F Pattou, G Alm, J Lefebvre, P Wattré, D Hober.   

Abstract

The interactions of coxsackievirus B3 (CVB3), CVB4E2 (diabetogenic), and CVB4JBV (nondiabetogenic) strains with human pancreatic islets from eight adult brain-dead donors were investigated. Persistent replication of viruses in human islets was proved by detection of viral RNA by in situ hybridization, VP1 capsid protein by immunofluorescence (IF) staining, negative-strand viral RNA by reverse transcription-PCR in extracted RNA from islets, and release of infectious particles up to 30 days after infection without obvious cytolysis. By double IF staining, glucagon-containing alpha cells and insulin-containing beta cells were shown to be susceptible to CVB. The persistence of CVB3 and CVB4 in islet cells was associated with the chronic synthesis of alpha interferon (IFN-alpha), as evidenced by the detection of IFN-alpha mRNA and immunoreactive IFN-alpha with antiviral activity. By double IF staining, IFN-alpha was detected in insulin-producing beta cells only. Experiments with neutralizing anti-coxsackievirus and adenovirus receptor (CAR) antibodies provided evidence that CAR was expressed by alpha and beta cells and that it played a role in the infection of these cells with CVB and the consecutive IFN-alpha expression in beta cells. The viral replication and the expression of IFN-alpha in islets were not restricted to the CVB4E2 diabetogenic strain and did not depend on the genetic background of the host. The neutralization of endogenous IFN-alpha significantly enhanced the CVB replication in islet cells and resulted in rapid destruction of islets. Thus, human beta cells can harbor a persistent CVB infection, and CVB-induced IFN-alpha plays a role in the initiation and/or maintenance of chronic CVB infection in human islets.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11024144      PMCID: PMC102054          DOI: 10.1128/jvi.74.21.10153-10164.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells.

Authors:  M Roivainen; S Rasilainen; P Ylipaasto; R Nissinen; J Ustinov; L Bouwens; D L Eizirik; T Hovi; T Otonkoski
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

2.  Systemic lymphoid atrophy in coxsackievirus B3-infected mice: effects of virus and immunopotentiating agents.

Authors:  D Matteucci; A Toniolo; P G Conaldi; F Basolo; Z Gori; M Bendinelli
Journal:  J Infect Dis       Date:  1985-06       Impact factor: 5.226

3.  Persistent infection of rat insulinoma cells with Coxsackie B4 virus. Brief report.

Authors:  J A Frank; E V Schmidt; R E Smith; C M Wilfert
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

4.  Isolation of a virus from the pancreas of a child with diabetic ketoacidosis.

Authors:  J W Yoon; M Austin; T Onodera; A L Notkins
Journal:  N Engl J Med       Date:  1979-05-24       Impact factor: 91.245

Review 5.  Interferons and their actions.

Authors:  S Pestka; J A Langer; K C Zoon; C E Samuel
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

6.  A new in vitro model for the study of pancreatic A and B cells.

Authors:  D G Pipeleers; P A in't Veld; M Van de Winkel; E Maes; F C Schuit; W Gepts
Journal:  Endocrinology       Date:  1985-09       Impact factor: 4.736

7.  The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses.

Authors:  J M Bergelson; A Krithivas; L Celi; G Droguett; M S Horwitz; T Wickham; R L Crowell; R W Finberg
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

8.  Virus-induced diabetes mellitus. XI. Replication of coxsackie B3 virus in human pancreatic beta cell cultures.

Authors:  J W Yoon; T Onodera; A B Jenson; A L Notkins
Journal:  Diabetes       Date:  1978-07       Impact factor: 9.461

9.  [Production of human type I interferon by lymphocytes in contact with cells infected by herpesvirus and fixed with glutaraldehyde].

Authors:  P Lebon; M J Commoy-Chevalier; B Robert-Galliot; A Morin; C Chany
Journal:  C R Seances Acad Sci D       Date:  1980-01-07

10.  Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus.

Authors:  A K Foulis; M A Farquharson; A Meager
Journal:  Lancet       Date:  1987-12-19       Impact factor: 79.321

View more
  53 in total

1.  Persistent infection of human thymic epithelial cells by coxsackievirus B4.

Authors:  Fabienne Brilot; Wassim Chehadeh; Chantal Charlet-Renard; Henri Martens; Vincent Geenen; Didier Hober
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

Review 2.  Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host.

Authors:  Didier Hober; Pierre Sauter
Journal:  Nat Rev Endocrinol       Date:  2010-03-30       Impact factor: 43.330

3.  Human astrocytic cells support persistent coxsackievirus B3 infection.

Authors:  Xiaowei Zhang; Zhenhua Zheng; Bo Shu; Xijuan Liu; Zhenfeng Zhang; Yan Liu; Bingke Bai; Qinxue Hu; Panyong Mao; Hanzhong Wang
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

Review 4.  Persistent viral infection in primary Sjogren's syndrome: review and perspectives.

Authors:  Antigoni Triantafyllopoulou; Haralampos Moutsopoulos
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

5.  New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.

Authors:  Lucie Fénéant; Julie Potel; Catherine François; Famara Sané; Florian Douam; Sandrine Belouzard; Noémie Calland; Thibaut Vausselin; Yves Rouillé; Véronique Descamps; Thomas F Baumert; Gilles Duverlie; Dimitri Lavillette; Didier Hober; Jean Dubuisson; Czeslaw Wychowski; Laurence Cocquerel
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

6.  Pancreatic beta cells persistently infected with coxsackievirus B4 are targets of NK cell-mediated cytolytic activity.

Authors:  Magloire Pandoua Nekoua; Antoine Bertin; Famara Sane; Enagnon Kazali Alidjinou; Delphine Lobert; Jacques Trauet; Christine Hober; Ilka Engelmann; Kabirou Moutairou; Akadiri Yessoufou; Didier Hober
Journal:  Cell Mol Life Sci       Date:  2019-06-06       Impact factor: 9.261

Review 7.  Enteroviral Infections as a Trigger for Type 1 Diabetes.

Authors:  Teresa Rodriguez-Calvo
Journal:  Curr Diab Rep       Date:  2018-09-19       Impact factor: 4.810

8.  Slow Infection due to Lowering the Amount of Intact versus Empty Particles Is a Characteristic Feature of Coxsackievirus B5 Dictated by the Structural Proteins.

Authors:  Paula Turkki; Mira Laajala; Marie Stark; Helena Vandesande; Heidi Sallinen-Dal Maso; Sailee Shroff; Anna Sävneby; Ganna Galitska; A Michael Lindberg; Varpu Marjomäki
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

9.  Coxsackievirus B4 infection of human fetal thymus cells.

Authors:  Fabienne Brilot; Vincent Geenen; Didier Hober; Cheryl A Stoddart
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Murine pancreatic beta TC3 cells show greater 2', 5'-oligoadenylate synthetase (2'5'AS) antiviral enzyme activity and apoptosis following IFN-alpha or poly(I:C) treatment than pancreatic alpha TC3 cells.

Authors:  M Li; D-J Zheng; L L Field; V Bonnevie-Nielsen
Journal:  Exp Diabetes Res       Date:  2009-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.